Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Hydromorphone Hydrochloride Sustained-release Tablets

Approval Number

国药准字H20234712

Company宜昌人福药业有限责任公司

Registration Date

December 29, 2023

Drug Information

Generic Name

盐酸氢吗啡酮缓释片

Dosage Form

片剂

Strength

8mg

Drug Type

化学药品

Registration Date

December 29, 2023

Company Information

Applicant Company

Company Name宜昌人福药业有限责任公司

Company Address

湖北省宜昌开发区大连路19号

Manufacturing Company

Company Name宜昌人福药业有限责任公司

Company Address

湖北省宜昌市东临路519号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸氢吗啡酮缓释片 - NMPA 批准文号 | MedPath